Literature DB >> 12384941

Radiographic healing with sustained clinical remission in a patient with rheumatoid arthritis receiving methotrexate monotherapy.

Siegfried Wassenberg1, Rolf Rau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12384941     DOI： 10.1002/art.10568

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  6 in total

Review 1.  [Methotrexate].

Authors:  R Rau
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

Review 2.  RANKL as a therapeutic target of rheumatoid arthritis.

Authors:  Sakae Tanaka; Yoshiya Tanaka
Journal:  J Bone Miner Metab       Date:  2020-10-18       Impact factor: 2.626

3.  Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways.

Authors:  Sakae Tanaka
Journal:  World J Orthop       Date:  2013-01-18

4.  The Effects of microRNA-515-5p on the Toll-Like Receptor 4 (TLR4)/JNK Signaling Pathway and WNT1-Inducible-Signaling Pathway Protein 1 (WISP-1) Expression in Rheumatoid Arthritis Fibroblast-Like Synovial (RAFLS) Cells Following Treatment with Receptor Activator of Nuclear Factor-kappa-B Ligand (RANKL).

Authors:  Dongfeng Cai; Song Hong; Jin Yang; Peng San
Journal:  Med Sci Monit       Date:  2020-05-03

Review 5.  RANKL is a therapeutic target of bone destruction in rheumatoid arthritis.

Authors:  Sakae Tanaka
Journal:  F1000Res       Date:  2019-04-23

Review 6.  Control of articular synovitis for bone and cartilage regeneration in rheumatoid arthritis.

Authors:  Hiromu Ito; Furu Moritoshi; Motomu Hashimoto; Masao Tanaka; Shuichi Matsuda
Journal:  Inflamm Regen       Date:  2018-04-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.